Sample profile and patient outcome to tocilizumab therapy.

Abstract

<p>Patient’s final outcome was based on their DAS28-CRP score 16 weeks after the first tocilizumab or etanerecept treatment. Non-naïve patients are those who had prior anti-cytokine treatment one to three times.</p